BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND CD79A, ENSG00000105369, 973, P11912, MB-1, IGA
353 results:

  • 1. Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive iga
    Xie Y; Huang Y; Li ZY; Jiang W; Shi NX; Lu Y; Cao G; Yin Z; Lin XJ
    Mol Cancer; 2024 May; 23(1):95. PubMed ID: 38720319
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Hepatitis B virus-related hepatocellular carcinoma has superior overall survival compared with other etiologies.
    Yen YH; Kee KM; Hu TH; Tsai MC; Kuo YH; Li WF; Liu YW; Wang CC; Lin CY
    PLoS One; 2024; 19(3):e0290523. PubMed ID: 38489301
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Adjuvant treatment with Cordyceps sinensis for lung cancer: A systematic review and meta-analysis of randomized controlled trials.
    Wang C; Wang J; Qi Y
    J Ethnopharmacol; 2024 Jun; 327():118044. PubMed ID: 38484953
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Outcomes of liver transplantation for hepatocellular carcinoma in donation after circulatory death compared with donation after brain death: A systematic review and meta-analysis.
    Al-Ameri AAM; Zheng S
    Ann Hepatol; 2024; 29(3):101484. PubMed ID: 38417629
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Immunologic landscape of human hepatic hemangiomas and epithelioid hemangioendotheliomas.
    Thomann S; Metzler T; Tóth M; Schirmacher P; Mogler C
    Hepatol Commun; 2024 Jan; 8(1):. PubMed ID: 38206210
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Sleep patterns, genetic predisposition, and risk of chronic liver disease: A prospective study of 408,560 UK Biobank participants.
    Wang W; Zhuang Z; Song Z; Zhao Y; Huang T
    J Affect Disord; 2024 May; 352():229-236. PubMed ID: 38199417
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Celiac Disease: Promising Biomarkers for Follow-Up.
    Hrunka M; Janda L; Šťastná M; Pinkasová T; Pecl J; Kunovský L; Dítě P; Jabandžiev P
    J Gastrointestin Liver Dis; 2023 Dec; 32(4):536-544. PubMed ID: 38147608
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia.
    Vu TT; Kim K; Manna M; Thomas J; Remaily BC; Montgomery EJ; Costa T; Granchie L; Xie Z; Guo Y; Chen M; Castillo AMM; Kulp SK; Mo X; Nimmagadda S; Gregorevic P; Owen DH; Ganesan LP; Mace TA; Coss CC; Phelps MA
    Pharmacol Res; 2024 Jan; 199():107048. PubMed ID: 38145833
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Associations between types and sources of dietary carbohydrates and liver fat: a UK Biobank study.
    Orliacq J; Pérez-Cornago A; Parry SA; Kelly RK; Koutoukidis DA; Carter JL
    BMC Med; 2023 Nov; 21(1):444. PubMed ID: 37968623
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Polymeric immunoglobulin receptor (pIgR) in cancer.
    Chae J; Choi J; Chung J
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17683-17690. PubMed ID: 37897659
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. 68 Ga-FAPI-04 Detected Hepatic Arteriovenous Malformation in a Patient With iga Nephropathy.
    Zhang Z; Ni X; Guo S; Zuo C; Cheng C
    Clin Nucl Med; 2023 Dec; 48(12):1096-1098. PubMed ID: 37883057
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Efficacy and safety of Xiao-ai-ping injection add-on therapy to chemotherapy in patients with non-small cell lung cancer: A systematic review and meta-analysis.
    Li A; Liu S; Zhang H; Lin M; Guo L; Yuan C; Li Z; Xu J; Wang T
    Medicine (Baltimore); 2023 Oct; 102(40):e35483. PubMed ID: 37800773
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A child with polyarthritis and chronic lung disease: a case report of ataxia-telangiectasia.
    De Nardi L; Natale MF; Messia V; Tomà P; De Benedetti F; Insalaco A
    Ital J Pediatr; 2023 Sep; 49(1):111. PubMed ID: 37667293
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Low-density lipoprotein cholesterol and risk of hepatocellular carcinoma: a Mendelian randomization and mediation analysis.
    Cao J; Wang Z; Zhu M; Huang Y; Jin Z; Xiong Z
    Lipids Health Dis; 2023 Jul; 22(1):110. PubMed ID: 37525197
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Nomogram based on Sonazoid contrast-enhanced ultrasound to differentiate intrahepatic cholangiocarcinoma and poorly differentiated hepatocellular carcinoma: a prospective multicenter study.
    Wang S; Yao J; Li K; Yang H; Lu S; He G; Wu W; Cheng W; Jiang T; Ding H; Jing X; Yan Y; Liu F; Yu J; Han Z; Cheng Z; Tan S; Li X; Dou J; Li Y; Qi E; Zhang Y; Liang P; Yu X
    Abdom Radiol (NY); 2023 Oct; 48(10):3101-3113. PubMed ID: 37436451
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. liver functional assessment using time-associated change in the liver-to-spleen signal intensity ratio on enhanced magnetic resonance imaging: a retrospective study.
    Kudo M; Gotohda N; Sugimoto M; Kobayashi S; Konishi M; Kobayashi T
    BMC Surg; 2023 Jun; 23(1):179. PubMed ID: 37370103
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary liver cancer.
    Chen Z; Zhang G; Ren X; Yao Z; Zhou Q; Ren X; Chen S; Xu L; Sun K; Zeng Q; Kuang M; Kuang DM; Peng S
    Cancer Res; 2023 Nov; 83(21):3544-3561. PubMed ID: 37352379
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A comprehensive evaluation of full-spectrum cell-free RNAs highlights cell-free RNA fragments for early-stage hepatocellular carcinoma detection.
    Ning C; Cai P; Liu X; Li G; Bao P; Yan L; Ning M; Tang K; Luo Y; Guo H; Wang Y; Wang Z; Chen L; Lu ZJ; Yin J
    EBioMedicine; 2023 Jul; 93():104645. PubMed ID: 37315449
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristics.
    Uzun S; Zinner CP; Beenen AC; Alborelli I; Bartoszek EM; Yeung J; Calgua B; Reinscheid M; Bronsert P; Stalder AK; Haslbauer JD; Vosbeck J; Mazzucchelli L; Hoffmann T; Terracciano LM; Hutter G; Manz M; Panne I; Boettler T; Hofmann M; Bengsch B; Heim MH; Bernsmeier C; Jiang S; Tzankov A; Terziroli Beretta-Piccoli B; Matter MS
    J Hepatol; 2023 Sep; 79(3):666-676. PubMed ID: 37290592
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma.
    Shang T; Jiang T; Lu T; Wang H; Cui X; Pan Y; Xu M; Pei M; Ding Z; Feng X; Lin Y; Li X; Tan Y; Feng F; Dong H; Wang H; Dong L
    Front Immunol; 2023; 14():1166497. PubMed ID: 37234171
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 18.